Teva Pharmaceuticals USA is expanding its nationwide recall of Losartan potassium tablets to an additional six lots: two lots of 50-mg tablets and four lots of 100-mg tablets. These are in addition to the lots already recalled back in April.
The recall is due to the detection of a likely carcinogen, N- Methylnitrosobutyric Acid (NMBA) that is appearing in levels exceeding the recommended exposure limits set forth by the U.S. Food and Drug Administration (FDA).
Losartan is typically used to control hypertension in adults (high blood pressure), diabetic nephropathy, Marfan Syndrome and other illnesses for which doctors have deemed it to be an appropriate course of treatment.
If you think your Losartan has been included in the recall, visit the FDA website for more information on the recall and call your doctor to see what his recommendation is for you. Do not stop taking your medication without seeking advice from your primary caregiver, first!
Did you know about this recall? Tell us what you think in the comments below. You can also contact us for more information! Feel free to shoot us an email to Outreach@ConsiderTheConsumer.com. You can also find us on Twitter, Facebook, Instagram, LinkedIn, or even connect with us directly on our website!
About the Author: Aisha K. Staggers is a writer, lecturer, political analyst and literary agent. She appears weekly for “Staggers’ State of Things” on the Dr. Vibe Show. Her work has been published by Paper Magazine, AfroPunk, The Spool, GREY Journal, MTV News, HuffPost, Blavity, Atlanta Blackstar, For Harriet, New York Review of Books and a host of other first-run publications and syndicated outlets. Find her on Twitter @AishaStaggers. For more of her work, check out her page here!